Cargando…

Up-regulation of the DR5 Expression by Proteasome Inhibitor MG132 Augments TRAIL-Induced Apoptosis in Soft Tissue Sarcoma Cell Lines

PURPOSE: Current chemotherapeutics for treating locally advanced or metastatic soft tissue sarcomas (STS) are limited. Accordingly, the present in vitro study was conducted to evaluate the effects of treatment of STS cells with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) applied...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheong, Hee-Jeong, Lee, Kyu Sang, Woo, In Sook, Won, Jong-Ho, Byun, Jae Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138916/ https://www.ncbi.nlm.nih.gov/pubmed/21811429 http://dx.doi.org/10.4143/crt.2011.43.2.124

Ejemplares similares

Transcriptional Upregulation of Plasminogen Activator Inhibitor-1 in Rat Primary Astrocytes by a Proteasomal Inhibitor MG132
por: Cho, Kyu Suk, et al.
Publicado: (2013)

The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish
por: Winder, Steve J, et al.
Publicado: (2011)

Proteasome inhibitor MG-132 induces MCPIP1 expression
por: Skalniak, Lukasz, et al.
Publicado: (2013)

Effects of proteasome inhibitor MG-132 on the parasite Schistosoma mansoni
por: Morais, Enyara R., et al.
Publicado: (2017)

Proteasome Inhibitor MG132 Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells and Inhibits Tumor Growth
por: Sun, Farui, et al.
Publicado: (2018)

Prolonged treatment with the proteasome inhibitor MG-132 induces apoptosis in PC12 rat pheochromocytoma cells
por: Tarjányi, Oktávia, et al.
Publicado: (2022)

Systemic Perturbation of the ERK Signaling Pathway by the Proteasome Inhibitor, MG132
por: Cirit, Murat, et al.
Publicado: (2012)

Proteasome inhibitor MG132 inhibits the process of renal interstitial fibrosis
por: Han, Lin, et al.
Publicado: (2019)

Stability of Zinc Finger Nuclease Protein Is Enhanced by the Proteasome Inhibitor MG132
por: Ramakrishna, Suresh, et al.
Publicado: (2013)

MG132-mediated inhibition of the ubiquitin–proteasome pathway ameliorates cancer cachexia
por: Zhang, Liuping, et al.
Publicado: (2013)

Systemic Analysis of Heat Shock Response Induced by Heat Shock and a Proteasome Inhibitor MG132
por: Kim, Hee-Jung, et al.
Publicado: (2011)

The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice
por: Caron, Annabelle Z, et al.
Publicado: (2011)

Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells
por: DANG, LIFENG, et al.
Publicado: (2014)

MG-132, an inhibitor of proteasomes and calpains, induced inhibition of oocyte maturation and aneuploidy in mouse oocytes
por: Mailhes, John B, et al.
Publicado: (2002)

Modulatory effect of MG-132 proteasomal inhibition on boar sperm motility during in vitro capacitation
por: Hackerova, Lenka, et al.
Publicado: (2023)

The Proteasome Inhibitor, MG132, Attenuates Diabetic Nephropathy by Inhibiting SnoN Degradation In Vivo and In Vitro
por: Huang, Wei, et al.
Publicado: (2014)

Proteomic Analysis of MG132-Treated Germinating Pollen Reveals Expression Signatures Associated with Proteasome Inhibition
por: Vannini, Candida, et al.
Publicado: (2014)

Upregulation of DR5 and Downregulation of Survivin by IITZ-01, Lysosomotropic Autophagy Inhibitor, Potentiates TRAIL-Mediated Apoptosis in Renal Cancer Cells via Ubiquitin-Proteasome Pathway
por: Shahriyar, Sk Abrar, et al.
Publicado: (2020)

MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion
por: PARK, WOO HYUN, et al.
Publicado: (2012)

Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of Geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis
por: Chen, Shuzhen, et al.
Publicado: (2010)

Blocking Plasmodium falciparum Development via Dual Inhibition of Hemoglobin Degradation and the Ubiquitin Proteasome System by MG132
por: Prasad, Rajesh, et al.
Publicado: (2013)

Enhanced efficacy against cervical carcinomas through polymeric micelles physically incorporating the proteasome inhibitor MG132
por: Matsumoto, Yoko, et al.
Publicado: (2016)

Proteasome inhibitor MG132 suppresses pancreatic ductal adenocarcinoma-cell migration by increasing ESE3 expression
por: Jin, Fanjie, et al.
Publicado: (2020)

The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis
por: van Dijk, Marianne, et al.
Publicado: (2011)

MCPIP1 contributes to the toxicity of proteasome inhibitor MG-132 in HeLa cells by the inhibition of NF-κB
por: Skalniak, Lukasz, et al.
Publicado: (2014)

Interplay of Autophagy Inducer Rapamycin and Proteasome Inhibitor MG132 in Reduction of Foam Cell Formation and Inflammatory Cytokine Expression
por: Zhang, Wei, et al.
Publicado: (2018)

Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss
por: Ortiz-Lazareno, Pablo César, et al.
Publicado: (2014)

Treatment with the Proteasome Inhibitor MG132 during the End of Oocyte Maturation Improves Oocyte Competence for Development after Fertilization in Cattle
por: You, Jinyoung, et al.
Publicado: (2012)

Proteasome Inhibitor MG132 is Toxic and Inhibits the Proliferation of Rat Neural Stem Cells but Increases BDNF Expression to Protect Neurons
por: Kim, Young Min, et al.
Publicado: (2020)

Chloroquine enhances TRAIL-mediated apoptosis through up-regulation of DR5 by stabilization of mRNA and protein in cancer cells
por: Park, Eun Jung, et al.
Publicado: (2016)

Chalcones and Dihydrochalcones Augment TRAIL-Mediated Apoptosis in Prostate Cancer Cells
por: Szliszka, Ewelina, et al.
Publicado: (2010)

The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism
por: Pajonk, Frank, et al.
Publicado: (2005)

Effect of addition of FSH, LH and proteasome inhibitor MG132 to in vitro maturation medium on the developmental competence of yak (Bos grunniens) oocytes
por: Xiao, Xiao, et al.
Publicado: (2014)

FTY720 enhances TRAIL-mediated apoptosis by up-regulating DR5 and down-regulating Mcl-1 in cancer cells
por: Woo, Seon Min, et al.
Publicado: (2015)

[Retracted] Proteasome inhibitor sensitizes oral squamous cell carcinoma cells to TRAIL‑mediated apoptosis
por: Yoshiba, Sayaka, et al.
Publicado: (2023)

Pentoxifylline and the proteasome inhibitor MG132 induce apoptosis in human leukemia U937 cells through a decrease in the expression of Bcl-2 and Bcl-XL and phosphorylation of p65
por: Bravo-Cuellar, Alejandro, et al.
Publicado: (2013)

Role of Endoplasmic Reticulum Stress in α-TEA Mediated TRAIL/DR5 Death Receptor Dependent Apoptosis
por: Tiwary, Richa, et al.
Publicado: (2010)

Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis
por: Zheng, Zheng, et al.
Publicado: (2023)

Polyphenols Isolated from Propolis Augment TRAIL-Induced Apoptosis in Cancer Cells
por: Szliszka, Ewelina, et al.
Publicado: (2013)

Regulation of TRAIL-Receptor Expression by the Ubiquitin-Proteasome System
por: Sarhan, Dhifaf, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pb7oqo7pk0f6hu9ge72q2sjaq7